C12N 2770/26071
Demonstrated in vivo effect
C12N2770/26071 (Demonstrated in vivo effect) appears on 3 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 3
- Assignees
- 1
- Inventors
- 2
- Latest grant
- 4 Jun 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
By publication year.
Recent patents
- Anti-cancer plant virus particles linked to HER2 antigens4 Jun 2024US 11,998,594 B2Case Western Reserve University
- Vaccination using plant virus particles linked to HER2 antigens26 May 2020US 10,660,949 B2Case Western Reserve University
- Vaccination using plant virus particles linked to HER2 antigens16 Oct 2018US 10,098,936 B2Case Western Reserve University
- Anti-cancer plant virus particles linked to her2 antigens4 Mar 2021US 2021/0060147 A1Case Western Reserve University
- Vaccination using plant virus particles linked to her2 antigens31 Jan 2019US 2019/0030148 A1Case Western Reserve University
- Vaccination using plant virus particles linked to her2 antigens26 Jan 2017US 2017/0021003 A1Case Western Reserve University
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.